Transcripts that associate with the RNA binding protein, DEAD-END (DND1), in embryonic stem (ES) cells

BMC Molecular Biology

Volumn 12, Issue , 2011, Pages

  Zhu, Rui ^a   Iacovino, Michelina ^b   Mahen, Elisabeth ^b   Kyba, Michael ^b   Matin, Angabin ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DEAD END PROTEIN 1; DOXYCYCLINE; HEMAGLUTTININ; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BAX; PROTEIN BCL X; PROTEIN LATS2; PROTEIN LIN28; PROTEIN P27; PROTEIN P53; RIBONUCLEOPROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; DND1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA MODIFICATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GERM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; REAL TIME POLYMERASE CHAIN REACTION; RNA BINDING; ANIMAL; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

MUS; VERTEBRATA;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE; EMBRYONIC STEM CELLS; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOPLASM PROTEINS; RIBONUCLEOPROTEINS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 80051799896     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-12-37     Document Type: Article

References (47)

1. Weidinger G, Stebler J, Slanchev K, Dumstrei K, Wise C, Lovell-Badge R, Thisse C, Thisse B, Raz E. dead end, a novel vertebrate germ plasm component, is required for zebrafish primordial germ cell migration and survival. Curr Biol 2003, 13(16):1429-1434. 10.1016/S0960-9822(03)00537-2, 12932328.
2. Youngren KK, Coveney D, Peng X, Bhattacharya C, Schmidt LS, Nickerson ML, Lamb BT, Deng JM, Behringer RR, Capel B, et al. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 2005, 435:360-364. 10.1038/nature03595, 1421521, 15902260.
3. Hayashi K, de Sousa Lopes SMC, Surani MA. Germ cell specification in mice. Science 2007, 314:394-396.
4. Saga Y. Mouse germ cell development during embryogenesis. Curr Opin Genet Dev 2008, 18:337-341. 10.1016/j.gde.2008.06.003, 18625315.
5. Noguchi T, Stevens LC. Primordial germ cell proliferation in fetal testes in mouse strains with high and low incidences of congenital testicular teratomas. J Natl Cancer Inst 1982, 69(4):907-913.
6. Noguchi T, Noguchi M. A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice. J Natl Cancer Inst 1985, 75(2):385-392.
7. Stevens LC. A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst 1973, 50(1):235-242.
8. Oosterhuis JW, Looijenga LHJ. Testicular germ-cell tumours in a broader perspective. Nature Rev Cancer 2005, 5:210-222.
9. Rescorla FJ. Pediatric germ cell tumors. Semin Surgical Oncology 1999, 16:144-158.
10. Slanchev K, Stebler J, Goudarzi M, Cojocaru V, Weidinger G, Raz E. Control of dead end localization and activity - implications for the function of the protein in antagonizing miRNA function. Mech Dev 2009, 126:270-277. 10.1016/j.mod.2008.10.006, 19013519.
11. Kedde M, Strasser MJ, Boldajipour B, Vrielink JA, Slanchev K, le Sage C, Nagel R, Voorhoeve PM, van Duijse J, Orom UA, et al. RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA. Cell 2007, 131:1273-1286. 10.1016/j.cell.2007.11.034, 18155131.
12. Linger R, Dudakia D, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, et al. Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes Cancer 2008, 47:247-252. 10.1002/gcc.20526, 3109865, 18069663.
13. Ketting RF. A Dead End for MicroRNAs. Cell 2007, 131:1226-1227. 10.1016/j.cell.2007.12.004, 18160032.
14. Bhattacharya C, Aggarwal S, Zhu R, Kumar M, Zhao M, Meistrich ML, Matin A. The mouse dead-end gene isoform alpha is necessary for germ cell and embryonic viability. Biochem Biophys Res Commun 2007, 355:194-199. 10.1016/j.bbrc.2007.01.138, 1855146, 17291453.
15. Yabuta Y, Kurimoto K, Ohinata Y, Seki Y, Saitou M. Gene expression dynamics during germline specification in mice identified by quantitative single-cell gene expression profiling. Biol Reprod 2006, 75:705-716. 10.1095/biolreprod.106.053686, 16870942.
16. Dyce PW, Toms D, Li J. Stem cells and germ cells: microRNA and gene expression signatures. Histol Histopathol 2010, 25(4):505-513.
17. Chen C, Ridzon D, Lee CT, Blake J, Sun Y, Strauss WM. Defining embryonic stem cell identity using differentition related microRNAs and their potential targets. Mamm Genome 2007, 18:316-327. 10.1007/s00335-007-9032-6, 17610011.
18. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific microRNAs. Dev Cell 2003, 5:351-358. 10.1016/S1534-5807(03)00227-2, 12919684.
19. Houbaviy HB, Dennis L, Jaenisch R, Sharp PA. Characterization of a highly variable eutherian microRNA gene. RNA 2005, 11:1245-1257. 10.1261/rna.2890305, 1370808, 15987809.
20. Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, Blelloch R. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 2008, 40:1478-1483. 10.1038/ng.250, 2630798, 18978791.
21. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W, Nielsen JE, Skakkebaek NE, Rajpert-De Meyts E, Leffers H. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 2004, 64:4736-4743. 10.1158/0008-5472.CAN-04-0679, 15256440.
22. Elliott AM, de Miguel MP, Rebel VI, Donovan PJ. Identifying genes differentially expressed between PGCs and ES cells reveals a role for CREB-binding protein in germ cell survival. Dev Biol 2007, 311:347-358. 10.1016/j.ydbio.2007.08.029, 17936260.
23. Clark AT. The Stem Cell Identity of Testicular Cancer. Stem Cell Rev 2007, 3:49-59. 10.1007/s12015-007-0002-x, 17873381.
24. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA 2003, 100:13350-13355. 10.1073/pnas.2235735100, 263817, 14595015.
25. Zwaka TP, Thomson JA. A germ cell origin of embryonic stem cells?. Development 2005, 132:227-233. 10.1242/dev.01586, 15623802.
26. Liu Y, Shin S, Zeng X, Zhan M, Gonzalez R, Mueller F-J, Schwartz CM, Xue H, Li H, Baker SC, et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Developmental Biology 2006, 6:20. 10.1186/1471-213X-6-20, 1523200, 16672070.
27. Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, Garner HR, Agha-Mohammadi S, Tassin A, Coppée F, et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J 2008, 27:2766-2779. 10.1038/emboj.2008.201, 2572182, 18833193.
28. Agha-Mohammadi S, O'Malley M, Etemad A, Wang Z, Xiao X, Lotze MT. Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med 2004, 6:817-828. 10.1002/jgm.566, 15241789.
29. Keene JD, Komisarow JM, Friedersdorf MB. RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nature Protocols 2006, 1(1):302-307. 10.1038/nprot.2006.47, 17406249.
30. Tai M-H, Chang C-C, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005, 26:495-502.
31. Bourguignon LYW, Peyrollier K, Xia W, Gilad E. Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells. J Biol Chem 2008, 283:17635-17651. 10.1074/jbc.M800109200, 2427357,2427357, 18441325.
32. Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer 2008, 122:1253-1260.
33. Voorhoeve PM, le Sage C, Schrier M, Gillis AJM, Stoop H, Nagel R, Liu Y-P, van Duijse J, Drost J, Griekspoor A, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006, 124:1169-1181. 10.1016/j.cell.2006.02.037, 16564011.
34. Li CY, Chu JY, Yu JK, Huang XQ, Liu XJ, Shi L, Che YC, Xie JY. Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA. Cell Research 2004, 14:473-479. 10.1038/sj.cr.7290250, 15625014.
35. Ting DT, Kyba M, Daley GQ. Inducible transgene expression in mouse stem cells. Methods Mol Med 2005, 105:23-46.
36. Kyba M, Perlingeiro RCR, Daley GQ. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002, 109:29-37. 10.1016/S0092-8674(02)00680-3, 11955444.
37. Townley-Tilson WHD, Pendergrass SA, Marzluff W, Whitfield ML. Genome-wide analysis of mRNAs bound to the histone stem-loop binding protein. RNA 2006, 12:1853-1867. 10.1261/rna.76006, 1581977, 16931877.
38. Baroni TE, Chittur SV, George AD, Tenenbaum SA. Advances in RIP-chip analysis: RNA-binding protein immunoprecipitation-microarray profiling. Methods Mol Biol 2008, 419:93-108. 10.1007/978-1-59745-033-1_6, 18369977.
39. Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 2004, 23:7050-7160.
40. Niwa H. How is pluripotency determined and maintained?. Development 2007, 134:635-646. 10.1242/dev.02787, 17215298.
41. Silva J, Smith A. Capturing pluripotency. Cell 2008, 132:532-536. 10.1016/j.cell.2008.02.006, 2427053, 18295569.
42. Cook MS, Munger SC, Nadeau JH, Capel B. Regulation of male germ cell cycle arrest and differentiation by DND1 is modulated by genetic background. Development 2011,
43. Almstrup K, Leffers H, Lothe RA, Skakkebaek NE, Sonne SB, Nielsen JE, Rajpert-De Meyts E, Skotheim RI. Improved gene expression signature of testicular carcinoma in situ. Int J Andrology 2007, 30:292-303.
44. Emerson RE, Ulbright TM. Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers. Pathology 2010, 42:344-355. 10.3109/00313021003767355, 20438407.
45. Sonne SB, Perrett RM, Nielsen JE, Baxter MA, Kristensen DM, Leffers H, Hanley NA, Rajpert-De Meyts E. Analysis of SOX2 expression in developing human testis and germ cell neoplasia. Int J Dev Biol 2010, 54:755-760. 10.1387/ijdb.082668ss, 19876845.
46. Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ, Mongan NP. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the Nanog, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 2009, 18:1093-1108. 10.1089/scd.2009.0113, 3135180, 19480567.
47. Boheler KR. Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle. J Cell Physiol 2009, 221:10-17. 10.1002/jcp.21866, 19562686.